With retatrutide and other multi-agonists on the horizon, we may soon see drugs that approach the effectiveness of bariatric surgery without the invasiveness
doi: 10.1002/hep.20023 57
CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence
This mode of administration might discourage some patients from adhering to the treatment due to the inconvenience or discomfort associated with injections
What a targeted study would look like A randomized human clinical trial comparing placebo to CLA alone, L-carnitine alone, and the combination over six to 12 months with body composition by DXA, fasting metabolic markers, kidney function and TMAO measurement would be ideal
Drug discovery and screening : In pharmaceutical research environments, Dihexa is incorporated into high-throughput screening assays and lead optimization protocols